Global Rotavirus Vaccines Market Growth 2025-2031
The global Rotavirus Vaccines market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15?34% of severe diarrhea in the developing world and 37?96% of severe diarrhea in the developed world. The vaccines decrease the risk of death among young children due to diarrhea. Immunizing babies decreases rates of disease among older people and those who have not been immunized.
The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. This should be done along with promoting breastfeeding, handwashing, clean water and good sanitation. It is given by mouth and requires two or three doses. It should be given starting around six weeks of age.
The vaccines are safe. This includes their use in people with HIV/AIDS. An earlier vaccine that is no longer used was linked to intussusception, but the current versions are not clearly linked. Due to a potential risk they are not recommended in babies who have had intussusception. The vaccines are made from weakened rotavirus.
The vaccine first became available in the United States in 2006. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.In the United States it is more than US$200. As of 2013 there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Rotavirus Vaccines Industry Forecast? looks at past sales and reviews total world Rotavirus Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Rotavirus Vaccines sales for 2025 through 2031. With Rotavirus Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rotavirus Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Rotavirus Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rotavirus Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Rotavirus Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rotavirus Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rotavirus Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Rotavirus Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Rotavirus Vaccines market?
What factors are driving Rotavirus Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rotavirus Vaccines market opportunities vary by end market size?
How does Rotavirus Vaccines break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15?34% of severe diarrhea in the developing world and 37?96% of severe diarrhea in the developed world. The vaccines decrease the risk of death among young children due to diarrhea. Immunizing babies decreases rates of disease among older people and those who have not been immunized.
The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. This should be done along with promoting breastfeeding, handwashing, clean water and good sanitation. It is given by mouth and requires two or three doses. It should be given starting around six weeks of age.
The vaccines are safe. This includes their use in people with HIV/AIDS. An earlier vaccine that is no longer used was linked to intussusception, but the current versions are not clearly linked. Due to a potential risk they are not recommended in babies who have had intussusception. The vaccines are made from weakened rotavirus.
The vaccine first became available in the United States in 2006. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.In the United States it is more than US$200. As of 2013 there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Rotavirus Vaccines Industry Forecast? looks at past sales and reviews total world Rotavirus Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Rotavirus Vaccines sales for 2025 through 2031. With Rotavirus Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rotavirus Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Rotavirus Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rotavirus Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Rotavirus Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rotavirus Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rotavirus Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Rotavirus Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Rotarix
- RotaTeq
- Rotavac
- Rotavin-M1
- Lanzhou lamb
- Others
- Adult
- Pediatric
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bharat Biotech
- Merck & Co., Inc
- GlaxoSmithKline plc
- Lanzhou Institute of Biological
- Bharat Biotech International Limited
What is the 10-year outlook for the global Rotavirus Vaccines market?
What factors are driving Rotavirus Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rotavirus Vaccines market opportunities vary by end market size?
How does Rotavirus Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rotavirus Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Rotavirus Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Rotavirus Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Rotavirus Vaccines Segment by Type
2.2.1 Rotarix
2.2.2 RotaTeq
2.2.3 Rotavac
2.2.4 Rotavin-M1
2.2.5 Lanzhou lamb
2.2.6 Others
2.3 Rotavirus Vaccines Sales by Type
2.3.1 Global Rotavirus Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Rotavirus Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Rotavirus Vaccines Sale Price by Type (2020-2025)
2.4 Rotavirus Vaccines Segment by Application
2.4.1 Adult
2.4.2 Pediatric
2.5 Rotavirus Vaccines Sales by Application
2.5.1 Global Rotavirus Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Rotavirus Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Rotavirus Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Rotavirus Vaccines Breakdown Data by Company
3.1.1 Global Rotavirus Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Rotavirus Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Rotavirus Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Rotavirus Vaccines Revenue by Company (2020-2025)
3.2.2 Global Rotavirus Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Rotavirus Vaccines Sale Price by Company
3.4 Key Manufacturers Rotavirus Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rotavirus Vaccines Product Location Distribution
3.4.2 Players Rotavirus Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ROTAVIRUS VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Rotavirus Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Rotavirus Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Rotavirus Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Rotavirus Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Rotavirus Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Rotavirus Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Rotavirus Vaccines Sales Growth
4.4 APAC Rotavirus Vaccines Sales Growth
4.5 Europe Rotavirus Vaccines Sales Growth
4.6 Middle East & Africa Rotavirus Vaccines Sales Growth
5 AMERICAS
5.1 Americas Rotavirus Vaccines Sales by Country
5.1.1 Americas Rotavirus Vaccines Sales by Country (2020-2025)
5.1.2 Americas Rotavirus Vaccines Revenue by Country (2020-2025)
5.2 Americas Rotavirus Vaccines Sales by Type (2020-2025)
5.3 Americas Rotavirus Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rotavirus Vaccines Sales by Region
6.1.1 APAC Rotavirus Vaccines Sales by Region (2020-2025)
6.1.2 APAC Rotavirus Vaccines Revenue by Region (2020-2025)
6.2 APAC Rotavirus Vaccines Sales by Type (2020-2025)
6.3 APAC Rotavirus Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rotavirus Vaccines by Country
7.1.1 Europe Rotavirus Vaccines Sales by Country (2020-2025)
7.1.2 Europe Rotavirus Vaccines Revenue by Country (2020-2025)
7.2 Europe Rotavirus Vaccines Sales by Type (2020-2025)
7.3 Europe Rotavirus Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rotavirus Vaccines by Country
8.1.1 Middle East & Africa Rotavirus Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Rotavirus Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Rotavirus Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Rotavirus Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rotavirus Vaccines
10.3 Manufacturing Process Analysis of Rotavirus Vaccines
10.4 Industry Chain Structure of Rotavirus Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rotavirus Vaccines Distributors
11.3 Rotavirus Vaccines Customer
12 WORLD FORECAST REVIEW FOR ROTAVIRUS VACCINES BY GEOGRAPHIC REGION
12.1 Global Rotavirus Vaccines Market Size Forecast by Region
12.1.1 Global Rotavirus Vaccines Forecast by Region (2026-2031)
12.1.2 Global Rotavirus Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Rotavirus Vaccines Forecast by Type (2026-2031)
12.7 Global Rotavirus Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bharat Biotech
13.1.1 Bharat Biotech Company Information
13.1.2 Bharat Biotech Rotavirus Vaccines Product Portfolios and Specifications
13.1.3 Bharat Biotech Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bharat Biotech Main Business Overview
13.1.5 Bharat Biotech Latest Developments
13.2 Merck & Co., Inc
13.2.1 Merck & Co., Inc Company Information
13.2.2 Merck & Co., Inc Rotavirus Vaccines Product Portfolios and Specifications
13.2.3 Merck & Co., Inc Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck & Co., Inc Main Business Overview
13.2.5 Merck & Co., Inc Latest Developments
13.3 GlaxoSmithKline plc
13.3.1 GlaxoSmithKline plc Company Information
13.3.2 GlaxoSmithKline plc Rotavirus Vaccines Product Portfolios and Specifications
13.3.3 GlaxoSmithKline plc Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 GlaxoSmithKline plc Main Business Overview
13.3.5 GlaxoSmithKline plc Latest Developments
13.4 Lanzhou Institute of Biological
13.4.1 Lanzhou Institute of Biological Company Information
13.4.2 Lanzhou Institute of Biological Rotavirus Vaccines Product Portfolios and Specifications
13.4.3 Lanzhou Institute of Biological Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Lanzhou Institute of Biological Main Business Overview
13.4.5 Lanzhou Institute of Biological Latest Developments
13.5 Bharat Biotech International Limited
13.5.1 Bharat Biotech International Limited Company Information
13.5.2 Bharat Biotech International Limited Rotavirus Vaccines Product Portfolios and Specifications
13.5.3 Bharat Biotech International Limited Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Bharat Biotech International Limited Main Business Overview
13.5.5 Bharat Biotech International Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rotavirus Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Rotavirus Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Rotavirus Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Rotavirus Vaccines Segment by Type
2.2.1 Rotarix
2.2.2 RotaTeq
2.2.3 Rotavac
2.2.4 Rotavin-M1
2.2.5 Lanzhou lamb
2.2.6 Others
2.3 Rotavirus Vaccines Sales by Type
2.3.1 Global Rotavirus Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Rotavirus Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Rotavirus Vaccines Sale Price by Type (2020-2025)
2.4 Rotavirus Vaccines Segment by Application
2.4.1 Adult
2.4.2 Pediatric
2.5 Rotavirus Vaccines Sales by Application
2.5.1 Global Rotavirus Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Rotavirus Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Rotavirus Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Rotavirus Vaccines Breakdown Data by Company
3.1.1 Global Rotavirus Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Rotavirus Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Rotavirus Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Rotavirus Vaccines Revenue by Company (2020-2025)
3.2.2 Global Rotavirus Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Rotavirus Vaccines Sale Price by Company
3.4 Key Manufacturers Rotavirus Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rotavirus Vaccines Product Location Distribution
3.4.2 Players Rotavirus Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ROTAVIRUS VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Rotavirus Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Rotavirus Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Rotavirus Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Rotavirus Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Rotavirus Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Rotavirus Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Rotavirus Vaccines Sales Growth
4.4 APAC Rotavirus Vaccines Sales Growth
4.5 Europe Rotavirus Vaccines Sales Growth
4.6 Middle East & Africa Rotavirus Vaccines Sales Growth
5 AMERICAS
5.1 Americas Rotavirus Vaccines Sales by Country
5.1.1 Americas Rotavirus Vaccines Sales by Country (2020-2025)
5.1.2 Americas Rotavirus Vaccines Revenue by Country (2020-2025)
5.2 Americas Rotavirus Vaccines Sales by Type (2020-2025)
5.3 Americas Rotavirus Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rotavirus Vaccines Sales by Region
6.1.1 APAC Rotavirus Vaccines Sales by Region (2020-2025)
6.1.2 APAC Rotavirus Vaccines Revenue by Region (2020-2025)
6.2 APAC Rotavirus Vaccines Sales by Type (2020-2025)
6.3 APAC Rotavirus Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rotavirus Vaccines by Country
7.1.1 Europe Rotavirus Vaccines Sales by Country (2020-2025)
7.1.2 Europe Rotavirus Vaccines Revenue by Country (2020-2025)
7.2 Europe Rotavirus Vaccines Sales by Type (2020-2025)
7.3 Europe Rotavirus Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rotavirus Vaccines by Country
8.1.1 Middle East & Africa Rotavirus Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Rotavirus Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Rotavirus Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Rotavirus Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rotavirus Vaccines
10.3 Manufacturing Process Analysis of Rotavirus Vaccines
10.4 Industry Chain Structure of Rotavirus Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rotavirus Vaccines Distributors
11.3 Rotavirus Vaccines Customer
12 WORLD FORECAST REVIEW FOR ROTAVIRUS VACCINES BY GEOGRAPHIC REGION
12.1 Global Rotavirus Vaccines Market Size Forecast by Region
12.1.1 Global Rotavirus Vaccines Forecast by Region (2026-2031)
12.1.2 Global Rotavirus Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Rotavirus Vaccines Forecast by Type (2026-2031)
12.7 Global Rotavirus Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bharat Biotech
13.1.1 Bharat Biotech Company Information
13.1.2 Bharat Biotech Rotavirus Vaccines Product Portfolios and Specifications
13.1.3 Bharat Biotech Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bharat Biotech Main Business Overview
13.1.5 Bharat Biotech Latest Developments
13.2 Merck & Co., Inc
13.2.1 Merck & Co., Inc Company Information
13.2.2 Merck & Co., Inc Rotavirus Vaccines Product Portfolios and Specifications
13.2.3 Merck & Co., Inc Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck & Co., Inc Main Business Overview
13.2.5 Merck & Co., Inc Latest Developments
13.3 GlaxoSmithKline plc
13.3.1 GlaxoSmithKline plc Company Information
13.3.2 GlaxoSmithKline plc Rotavirus Vaccines Product Portfolios and Specifications
13.3.3 GlaxoSmithKline plc Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 GlaxoSmithKline plc Main Business Overview
13.3.5 GlaxoSmithKline plc Latest Developments
13.4 Lanzhou Institute of Biological
13.4.1 Lanzhou Institute of Biological Company Information
13.4.2 Lanzhou Institute of Biological Rotavirus Vaccines Product Portfolios and Specifications
13.4.3 Lanzhou Institute of Biological Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Lanzhou Institute of Biological Main Business Overview
13.4.5 Lanzhou Institute of Biological Latest Developments
13.5 Bharat Biotech International Limited
13.5.1 Bharat Biotech International Limited Company Information
13.5.2 Bharat Biotech International Limited Rotavirus Vaccines Product Portfolios and Specifications
13.5.3 Bharat Biotech International Limited Rotavirus Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Bharat Biotech International Limited Main Business Overview
13.5.5 Bharat Biotech International Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Rotavirus Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Rotavirus Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Rotarix
Table 4. Major Players of RotaTeq
Table 5. Major Players of Rotavac
Table 6. Major Players of Rotavin-M1
Table 7. Major Players of Lanzhou lamb
Table 8. Major Players of Others
Table 9. Global Rotavirus Vaccines Sales by Type (2020-2025) & (K Units)
Table 10. Global Rotavirus Vaccines Sales Market Share by Type (2020-2025)
Table 11. Global Rotavirus Vaccines Revenue by Type (2020-2025) & ($ million)
Table 12. Global Rotavirus Vaccines Revenue Market Share by Type (2020-2025)
Table 13. Global Rotavirus Vaccines Sale Price by Type (2020-2025) & (USD/Unit)
Table 14. Global Rotavirus Vaccines Sale by Application (2020-2025) & (K Units)
Table 15. Global Rotavirus Vaccines Sale Market Share by Application (2020-2025)
Table 16. Global Rotavirus Vaccines Revenue by Application (2020-2025) & ($ million)
Table 17. Global Rotavirus Vaccines Revenue Market Share by Application (2020-2025)
Table 18. Global Rotavirus Vaccines Sale Price by Application (2020-2025) & (USD/Unit)
Table 19. Global Rotavirus Vaccines Sales by Company (2020-2025) & (K Units)
Table 20. Global Rotavirus Vaccines Sales Market Share by Company (2020-2025)
Table 21. Global Rotavirus Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Rotavirus Vaccines Revenue Market Share by Company (2020-2025)
Table 23. Global Rotavirus Vaccines Sale Price by Company (2020-2025) & (USD/Unit)
Table 24. Key Manufacturers Rotavirus Vaccines Producing Area Distribution and Sales Area
Table 25. Players Rotavirus Vaccines Products Offered
Table 26. Rotavirus Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Rotavirus Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 30. Global Rotavirus Vaccines Sales Market Share Geographic Region (2020-2025)
Table 31. Global Rotavirus Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Rotavirus Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Rotavirus Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 34. Global Rotavirus Vaccines Sales Market Share by Country/Region (2020-2025)
Table 35. Global Rotavirus Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Rotavirus Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Rotavirus Vaccines Sales by Country (2020-2025) & (K Units)
Table 38. Americas Rotavirus Vaccines Sales Market Share by Country (2020-2025)
Table 39. Americas Rotavirus Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Rotavirus Vaccines Sales by Type (2020-2025) & (K Units)
Table 41. Americas Rotavirus Vaccines Sales by Application (2020-2025) & (K Units)
Table 42. APAC Rotavirus Vaccines Sales by Region (2020-2025) & (K Units)
Table 43. APAC Rotavirus Vaccines Sales Market Share by Region (2020-2025)
Table 44. APAC Rotavirus Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Rotavirus Vaccines Sales by Type (2020-2025) & (K Units)
Table 46. APAC Rotavirus Vaccines Sales by Application (2020-2025) & (K Units)
Table 47. Europe Rotavirus Vaccines Sales by Country (2020-2025) & (K Units)
Table 48. Europe Rotavirus Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Rotavirus Vaccines Sales by Type (2020-2025) & (K Units)
Table 50. Europe Rotavirus Vaccines Sales by Application (2020-2025) & (K Units)
Table 51. Middle East & Africa Rotavirus Vaccines Sales by Country (2020-2025) & (K Units)
Table 52. Middle East & Africa Rotavirus Vaccines Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Rotavirus Vaccines Sales by Type (2020-2025) & (K Units)
Table 54. Middle East & Africa Rotavirus Vaccines Sales by Application (2020-2025) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Rotavirus Vaccines
Table 56. Key Market Challenges & Risks of Rotavirus Vaccines
Table 57. Key Industry Trends of Rotavirus Vaccines
Table 58. Rotavirus Vaccines Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Rotavirus Vaccines Distributors List
Table 61. Rotavirus Vaccines Customer List
Table 62. Global Rotavirus Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 63. Global Rotavirus Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Americas Rotavirus Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Americas Rotavirus Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. APAC Rotavirus Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 67. APAC Rotavirus Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 68. Europe Rotavirus Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Europe Rotavirus Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Rotavirus Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 71. Middle East & Africa Rotavirus Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Global Rotavirus Vaccines Sales Forecast by Type (2026-2031) & (K Units)
Table 73. Global Rotavirus Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 74. Global Rotavirus Vaccines Sales Forecast by Application (2026-2031) & (K Units)
Table 75. Global Rotavirus Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 76. Bharat Biotech Basic Information, Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 77. Bharat Biotech Rotavirus Vaccines Product Portfolios and Specifications
Table 78. Bharat Biotech Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 79. Bharat Biotech Main Business
Table 80. Bharat Biotech Latest Developments
Table 81. Merck & Co., Inc Basic Information, Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 82. Merck & Co., Inc Rotavirus Vaccines Product Portfolios and Specifications
Table 83. Merck & Co., Inc Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. Merck & Co., Inc Main Business
Table 85. Merck & Co., Inc Latest Developments
Table 86. GlaxoSmithKline plc Basic Information, Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 87. GlaxoSmithKline plc Rotavirus Vaccines Product Portfolios and Specifications
Table 88. GlaxoSmithKline plc Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 89. GlaxoSmithKline plc Main Business
Table 90. GlaxoSmithKline plc Latest Developments
Table 91. Lanzhou Institute of Biological Basic Information, Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 92. Lanzhou Institute of Biological Rotavirus Vaccines Product Portfolios and Specifications
Table 93. Lanzhou Institute of Biological Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 94. Lanzhou Institute of Biological Main Business
Table 95. Lanzhou Institute of Biological Latest Developments
Table 96. Bharat Biotech International Limited Basic Information, Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 97. Bharat Biotech International Limited Rotavirus Vaccines Product Portfolios and Specifications
Table 98. Bharat Biotech International Limited Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 99. Bharat Biotech International Limited Main Business
Table 100. Bharat Biotech International Limited Latest Developments
Table 1. Rotavirus Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Rotavirus Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Rotarix
Table 4. Major Players of RotaTeq
Table 5. Major Players of Rotavac
Table 6. Major Players of Rotavin-M1
Table 7. Major Players of Lanzhou lamb
Table 8. Major Players of Others
Table 9. Global Rotavirus Vaccines Sales by Type (2020-2025) & (K Units)
Table 10. Global Rotavirus Vaccines Sales Market Share by Type (2020-2025)
Table 11. Global Rotavirus Vaccines Revenue by Type (2020-2025) & ($ million)
Table 12. Global Rotavirus Vaccines Revenue Market Share by Type (2020-2025)
Table 13. Global Rotavirus Vaccines Sale Price by Type (2020-2025) & (USD/Unit)
Table 14. Global Rotavirus Vaccines Sale by Application (2020-2025) & (K Units)
Table 15. Global Rotavirus Vaccines Sale Market Share by Application (2020-2025)
Table 16. Global Rotavirus Vaccines Revenue by Application (2020-2025) & ($ million)
Table 17. Global Rotavirus Vaccines Revenue Market Share by Application (2020-2025)
Table 18. Global Rotavirus Vaccines Sale Price by Application (2020-2025) & (USD/Unit)
Table 19. Global Rotavirus Vaccines Sales by Company (2020-2025) & (K Units)
Table 20. Global Rotavirus Vaccines Sales Market Share by Company (2020-2025)
Table 21. Global Rotavirus Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Rotavirus Vaccines Revenue Market Share by Company (2020-2025)
Table 23. Global Rotavirus Vaccines Sale Price by Company (2020-2025) & (USD/Unit)
Table 24. Key Manufacturers Rotavirus Vaccines Producing Area Distribution and Sales Area
Table 25. Players Rotavirus Vaccines Products Offered
Table 26. Rotavirus Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Rotavirus Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 30. Global Rotavirus Vaccines Sales Market Share Geographic Region (2020-2025)
Table 31. Global Rotavirus Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Rotavirus Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Rotavirus Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 34. Global Rotavirus Vaccines Sales Market Share by Country/Region (2020-2025)
Table 35. Global Rotavirus Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Rotavirus Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Rotavirus Vaccines Sales by Country (2020-2025) & (K Units)
Table 38. Americas Rotavirus Vaccines Sales Market Share by Country (2020-2025)
Table 39. Americas Rotavirus Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Rotavirus Vaccines Sales by Type (2020-2025) & (K Units)
Table 41. Americas Rotavirus Vaccines Sales by Application (2020-2025) & (K Units)
Table 42. APAC Rotavirus Vaccines Sales by Region (2020-2025) & (K Units)
Table 43. APAC Rotavirus Vaccines Sales Market Share by Region (2020-2025)
Table 44. APAC Rotavirus Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Rotavirus Vaccines Sales by Type (2020-2025) & (K Units)
Table 46. APAC Rotavirus Vaccines Sales by Application (2020-2025) & (K Units)
Table 47. Europe Rotavirus Vaccines Sales by Country (2020-2025) & (K Units)
Table 48. Europe Rotavirus Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Rotavirus Vaccines Sales by Type (2020-2025) & (K Units)
Table 50. Europe Rotavirus Vaccines Sales by Application (2020-2025) & (K Units)
Table 51. Middle East & Africa Rotavirus Vaccines Sales by Country (2020-2025) & (K Units)
Table 52. Middle East & Africa Rotavirus Vaccines Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Rotavirus Vaccines Sales by Type (2020-2025) & (K Units)
Table 54. Middle East & Africa Rotavirus Vaccines Sales by Application (2020-2025) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Rotavirus Vaccines
Table 56. Key Market Challenges & Risks of Rotavirus Vaccines
Table 57. Key Industry Trends of Rotavirus Vaccines
Table 58. Rotavirus Vaccines Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Rotavirus Vaccines Distributors List
Table 61. Rotavirus Vaccines Customer List
Table 62. Global Rotavirus Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 63. Global Rotavirus Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Americas Rotavirus Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Americas Rotavirus Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. APAC Rotavirus Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 67. APAC Rotavirus Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 68. Europe Rotavirus Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Europe Rotavirus Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Rotavirus Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 71. Middle East & Africa Rotavirus Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Global Rotavirus Vaccines Sales Forecast by Type (2026-2031) & (K Units)
Table 73. Global Rotavirus Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 74. Global Rotavirus Vaccines Sales Forecast by Application (2026-2031) & (K Units)
Table 75. Global Rotavirus Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 76. Bharat Biotech Basic Information, Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 77. Bharat Biotech Rotavirus Vaccines Product Portfolios and Specifications
Table 78. Bharat Biotech Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 79. Bharat Biotech Main Business
Table 80. Bharat Biotech Latest Developments
Table 81. Merck & Co., Inc Basic Information, Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 82. Merck & Co., Inc Rotavirus Vaccines Product Portfolios and Specifications
Table 83. Merck & Co., Inc Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. Merck & Co., Inc Main Business
Table 85. Merck & Co., Inc Latest Developments
Table 86. GlaxoSmithKline plc Basic Information, Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 87. GlaxoSmithKline plc Rotavirus Vaccines Product Portfolios and Specifications
Table 88. GlaxoSmithKline plc Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 89. GlaxoSmithKline plc Main Business
Table 90. GlaxoSmithKline plc Latest Developments
Table 91. Lanzhou Institute of Biological Basic Information, Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 92. Lanzhou Institute of Biological Rotavirus Vaccines Product Portfolios and Specifications
Table 93. Lanzhou Institute of Biological Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 94. Lanzhou Institute of Biological Main Business
Table 95. Lanzhou Institute of Biological Latest Developments
Table 96. Bharat Biotech International Limited Basic Information, Rotavirus Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 97. Bharat Biotech International Limited Rotavirus Vaccines Product Portfolios and Specifications
Table 98. Bharat Biotech International Limited Rotavirus Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 99. Bharat Biotech International Limited Main Business
Table 100. Bharat Biotech International Limited Latest Developments
LIST OF FIGURES
Figure 1. Picture of Rotavirus Vaccines
Figure 2. Rotavirus Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rotavirus Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Rotavirus Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Rotavirus Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Rotavirus Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Rotavirus Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Rotarix
Figure 12. Product Picture of RotaTeq
Figure 13. Product Picture of Rotavac
Figure 14. Product Picture of Rotavin-M1
Figure 15. Product Picture of Lanzhou lamb
Figure 16. Product Picture of Others
Figure 17. Global Rotavirus Vaccines Sales Market Share by Type in 2025
Figure 18. Global Rotavirus Vaccines Revenue Market Share by Type (2020-2025)
Figure 19. Rotavirus Vaccines Consumed in Adult
Figure 20. Global Rotavirus Vaccines Market: Adult (2020-2025) & (K Units)
Figure 21. Rotavirus Vaccines Consumed in Pediatric
Figure 22. Global Rotavirus Vaccines Market: Pediatric (2020-2025) & (K Units)
Figure 23. Global Rotavirus Vaccines Sale Market Share by Application (2024)
Figure 24. Global Rotavirus Vaccines Revenue Market Share by Application in 2025
Figure 25. Rotavirus Vaccines Sales by Company in 2025 (K Units)
Figure 26. Global Rotavirus Vaccines Sales Market Share by Company in 2025
Figure 27. Rotavirus Vaccines Revenue by Company in 2025 ($ millions)
Figure 28. Global Rotavirus Vaccines Revenue Market Share by Company in 2025
Figure 29. Global Rotavirus Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Rotavirus Vaccines Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Rotavirus Vaccines Sales 2020-2025 (K Units)
Figure 32. Americas Rotavirus Vaccines Revenue 2020-2025 ($ millions)
Figure 33. APAC Rotavirus Vaccines Sales 2020-2025 (K Units)
Figure 34. APAC Rotavirus Vaccines Revenue 2020-2025 ($ millions)
Figure 35. Europe Rotavirus Vaccines Sales 2020-2025 (K Units)
Figure 36. Europe Rotavirus Vaccines Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Rotavirus Vaccines Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Rotavirus Vaccines Revenue 2020-2025 ($ millions)
Figure 39. Americas Rotavirus Vaccines Sales Market Share by Country in 2025
Figure 40. Americas Rotavirus Vaccines Revenue Market Share by Country (2020-2025)
Figure 41. Americas Rotavirus Vaccines Sales Market Share by Type (2020-2025)
Figure 42. Americas Rotavirus Vaccines Sales Market Share by Application (2020-2025)
Figure 43. United States Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Rotavirus Vaccines Sales Market Share by Region in 2025
Figure 48. APAC Rotavirus Vaccines Revenue Market Share by Region (2020-2025)
Figure 49. APAC Rotavirus Vaccines Sales Market Share by Type (2020-2025)
Figure 50. APAC Rotavirus Vaccines Sales Market Share by Application (2020-2025)
Figure 51. China Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. India Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Rotavirus Vaccines Sales Market Share by Country in 2025
Figure 59. Europe Rotavirus Vaccines Revenue Market Share by Country (2020-2025)
Figure 60. Europe Rotavirus Vaccines Sales Market Share by Type (2020-2025)
Figure 61. Europe Rotavirus Vaccines Sales Market Share by Application (2020-2025)
Figure 62. Germany Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. France Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Rotavirus Vaccines Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Rotavirus Vaccines Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Rotavirus Vaccines Sales Market Share by Application (2020-2025)
Figure 70. Egypt Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Rotavirus Vaccines in 2025
Figure 76. Manufacturing Process Analysis of Rotavirus Vaccines
Figure 77. Industry Chain Structure of Rotavirus Vaccines
Figure 78. Channels of Distribution
Figure 79. Global Rotavirus Vaccines Sales Market Forecast by Region (2026-2031)
Figure 80. Global Rotavirus Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Rotavirus Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Rotavirus Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Rotavirus Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Rotavirus Vaccines Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Rotavirus Vaccines
Figure 2. Rotavirus Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rotavirus Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Rotavirus Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Rotavirus Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Rotavirus Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Rotavirus Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Rotarix
Figure 12. Product Picture of RotaTeq
Figure 13. Product Picture of Rotavac
Figure 14. Product Picture of Rotavin-M1
Figure 15. Product Picture of Lanzhou lamb
Figure 16. Product Picture of Others
Figure 17. Global Rotavirus Vaccines Sales Market Share by Type in 2025
Figure 18. Global Rotavirus Vaccines Revenue Market Share by Type (2020-2025)
Figure 19. Rotavirus Vaccines Consumed in Adult
Figure 20. Global Rotavirus Vaccines Market: Adult (2020-2025) & (K Units)
Figure 21. Rotavirus Vaccines Consumed in Pediatric
Figure 22. Global Rotavirus Vaccines Market: Pediatric (2020-2025) & (K Units)
Figure 23. Global Rotavirus Vaccines Sale Market Share by Application (2024)
Figure 24. Global Rotavirus Vaccines Revenue Market Share by Application in 2025
Figure 25. Rotavirus Vaccines Sales by Company in 2025 (K Units)
Figure 26. Global Rotavirus Vaccines Sales Market Share by Company in 2025
Figure 27. Rotavirus Vaccines Revenue by Company in 2025 ($ millions)
Figure 28. Global Rotavirus Vaccines Revenue Market Share by Company in 2025
Figure 29. Global Rotavirus Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Rotavirus Vaccines Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Rotavirus Vaccines Sales 2020-2025 (K Units)
Figure 32. Americas Rotavirus Vaccines Revenue 2020-2025 ($ millions)
Figure 33. APAC Rotavirus Vaccines Sales 2020-2025 (K Units)
Figure 34. APAC Rotavirus Vaccines Revenue 2020-2025 ($ millions)
Figure 35. Europe Rotavirus Vaccines Sales 2020-2025 (K Units)
Figure 36. Europe Rotavirus Vaccines Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Rotavirus Vaccines Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Rotavirus Vaccines Revenue 2020-2025 ($ millions)
Figure 39. Americas Rotavirus Vaccines Sales Market Share by Country in 2025
Figure 40. Americas Rotavirus Vaccines Revenue Market Share by Country (2020-2025)
Figure 41. Americas Rotavirus Vaccines Sales Market Share by Type (2020-2025)
Figure 42. Americas Rotavirus Vaccines Sales Market Share by Application (2020-2025)
Figure 43. United States Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Rotavirus Vaccines Sales Market Share by Region in 2025
Figure 48. APAC Rotavirus Vaccines Revenue Market Share by Region (2020-2025)
Figure 49. APAC Rotavirus Vaccines Sales Market Share by Type (2020-2025)
Figure 50. APAC Rotavirus Vaccines Sales Market Share by Application (2020-2025)
Figure 51. China Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. India Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Rotavirus Vaccines Sales Market Share by Country in 2025
Figure 59. Europe Rotavirus Vaccines Revenue Market Share by Country (2020-2025)
Figure 60. Europe Rotavirus Vaccines Sales Market Share by Type (2020-2025)
Figure 61. Europe Rotavirus Vaccines Sales Market Share by Application (2020-2025)
Figure 62. Germany Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. France Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Rotavirus Vaccines Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Rotavirus Vaccines Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Rotavirus Vaccines Sales Market Share by Application (2020-2025)
Figure 70. Egypt Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Rotavirus Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Rotavirus Vaccines in 2025
Figure 76. Manufacturing Process Analysis of Rotavirus Vaccines
Figure 77. Industry Chain Structure of Rotavirus Vaccines
Figure 78. Channels of Distribution
Figure 79. Global Rotavirus Vaccines Sales Market Forecast by Region (2026-2031)
Figure 80. Global Rotavirus Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Rotavirus Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Rotavirus Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Rotavirus Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Rotavirus Vaccines Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Fetal and Maternal Monitor Market Growth 2023-2029
US$ 3,660.00
March 2023
102 pages
Global Dental Air Polishing Unit Market Growth 2024-2030
US$ 3,660.00
September 2024
116 pages
Global Cytocentrifuge Market Growth 2024-2030
US$ 3,660.00
October 2024
116 pages
Global Immunoprecipitation Kit Market Growth 2023-2029
US$ 3,660.00
February 2023
117 pages
Global Artificial Limbs Market Growth 2024-2030
US$ 3,660.00
November 2024
90 pages
